Ad- and EBV-specific precursor frequencies/106 T cells
| . | Adenovirus . | . | EBV . | . | ||
|---|---|---|---|---|---|---|
| Donor . | CD4 isolated . | CD8 isolated . | CD4 isolated . | CD8 isolated . | ||
| 1 | nt | nt | 3180 | 6 080 | ||
| 2 | 1320 | 500 | 780 | 6 380 | ||
| 3 | 1640 | 240 | 0 (seronegative) | 0 (seronegative) | ||
| 4 | 1860 | 680 | 540 | 4 300 | ||
| 5 | 5600 | 900 | 380 | 3 460 | ||
| 6 | nt | nt | 3060 | 12 040 | ||
| 7 | 2020 | 2880 | 380 | 4 100 | ||
| 8 | 1120 | 540 | nt | nt | ||
| 9 | nt | nt | 3200 | 6 500 | ||
| 10 | nt | nt | 3960 | 4 840 | ||
| 11 | nt | nt | 200 | 680 | ||
| 12 | nt | nt | 3420 | 9 200 | ||
| . | Adenovirus . | . | EBV . | . | ||
|---|---|---|---|---|---|---|
| Donor . | CD4 isolated . | CD8 isolated . | CD4 isolated . | CD8 isolated . | ||
| 1 | nt | nt | 3180 | 6 080 | ||
| 2 | 1320 | 500 | 780 | 6 380 | ||
| 3 | 1640 | 240 | 0 (seronegative) | 0 (seronegative) | ||
| 4 | 1860 | 680 | 540 | 4 300 | ||
| 5 | 5600 | 900 | 380 | 3 460 | ||
| 6 | nt | nt | 3060 | 12 040 | ||
| 7 | 2020 | 2880 | 380 | 4 100 | ||
| 8 | 1120 | 540 | nt | nt | ||
| 9 | nt | nt | 3200 | 6 500 | ||
| 10 | nt | nt | 3960 | 4 840 | ||
| 11 | nt | nt | 200 | 680 | ||
| 12 | nt | nt | 3420 | 9 200 | ||
nt indicates not tested.